PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NON-ALCOHOLIC FATTY LIVER INFILTRATION, CONTAINING GPR119 LIGAND AS ACTIVE INGREDIENT Russian patent published in 2022 - IPC A61K31/445 A61K31/454 A61P1/16 

Abstract RU 2768943 C1

FIELD: medicine; pharmacology.

SUBSTANCE: group of inventions refers to pharmacology and medicine and aims at preventing or treating non-alcoholic fatty liver infiltration. In particular, the use of a compound corresponding to the following chemical formula 1, or pharmaceutically acceptable salts thereof, is described for preventing or treating non-alcoholic fatty liver infiltration: where A is oxadiazole, wherein A is independently substituted or substituted with at least one substituent selected from the group consisting of straight and branched C1-C6 alkyl; B is pyrimidine, B is independently substituted or substituted with at least one substituent selected from the group consisting of straight and branched C1-C6 alkyl; and X is independently F. In addition, methods for preventing or treating non-alcoholic fatty liver infiltration and use of a compound of formula 1, or its pharmaceutically acceptable salts, for preparing a drug for preventing or treating non-alcoholic fatty liver infiltration.

[Chemical formula 1].

EFFECT: providing effective prevention or treatment of non-alcoholic fatty liver infiltration.

9 cl, 16 dwg, 3 ex

Similar patents RU2768943C1

Title Year Author Number
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHOEPATITIS 2021
  • Kim, Mi-Kyung
  • Park, Hansu
  • Lee, Seung Ho
RU2803733C1
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF DIABETES AND RELATED METABOLIC DISEASES 2021
  • Kim, Mi-Kiung
  • Kim, Tae Khioung
  • Dzung, Ii Khoon
  • Chae, Yu Na
  • Yang, Dzae Sung
RU2809286C1
COMPOUND HAVING AGONISTIC ACTIVITY AGAINST GPR119, METHOD FOR ITS PREPARATION, AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS AN EFFECTIVE COMPONENT 2015
  • Yang Jae Sung
  • Baek Gye Rim
  • Kim Yoon Jung
  • Ahn Chi Young
  • Lee Jae Young
  • Jung Il Hoon
  • Kim Mi Kyung
  • Kang So Mi
  • Lee Hyo Ju
  • Chae Yu Na
  • Cheong Ye Hwang
  • Kim Tae Hyoung
  • Yang Eun Kyoung
  • Son Moon Ho
  • Shin Chang Yell
RU2670197C1
COMBINATIONS FOR TREATING NASH/NAFLD AND ASSOCIATED DISEASES 2019
  • Esler, William Paul
  • Ross, Trenton Thomas
RU2776369C1
HETEROCYCLIC SUBSTANCES-GPR119 AGONISTS 2017
  • Patil, Rakesh Ishwar
  • Verma, Jeevan
  • Kumar, Puneet
  • Gunjal, Amol, Pandurang
  • Rai, Himanshu
  • Rai, Santosh Kumar
  • Kumar, Anil
RU2734500C2
COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS 2008
  • Alper Fillip
  • Azimioara Mikhaj
  • Kau Kristofer
  • Ehpple Robert
  • Tszjan Sonchun'
  • Lele Zheral'
  • Mishelli P'Er-Iv
  • Mutnik Daniel
  • Nikulin Viktor
  • Uehstkott-Bejker Lukas
RU2443699C2
NOVEL PHARMACEUTICAL USE OF THIENO[3,2-D]PYRIMIDIN-4-ONE COMPOUNDS 2019
  • Liu, Hong
  • Li, Jia
  • Wang, Jiang
  • Zang, Yi
  • Li, Jian
  • Li, Jingya
  • Sun, Dandan
  • Jiang, Hualiang
  • Chen, Kaixian
RU2768828C1
METHOD OF MODELING NON-ALCOHOLIC STEATOHEPATITIS IN RATS 2009
  • Karaman Julija Konstantinovna
  • Novgorodtseva Tat'Jana Pavlovna
  • Bival'Kevich Natal'Ja Vladimirovna
  • Lobanova Elena Grigor'Evna
RU2394281C1
THERAPEUTIC AGENT FOR LIVER DISEASES 2018
  • Moon, Sung Hwan
  • Lee, Soo Jin
  • Lee, Sung Chan
  • Bae, Yun Soo
RU2723686C1
METHOD FOR MODELLING NON-ALCOHOLIC FATTY LIVER DISEASE BY DIET RICH IN FRUCTOSE 2019
  • Prokopenko Stanislav Evgenevich
  • Atyakshin Dmitrij Andreevich
  • Pritulina Yuliya Georgievna
  • Gerasimova Olga Andreevna
  • Salomakhin Yurij Georgievich
RU2728418C1

RU 2 768 943 C1

Authors

Kim, Mi-Kyung

Lee, Bo Ram

Park, Hansu

Lee, Seung Ho

Chae, Yu Na

Dates

2022-03-25Published

2019-09-11Filed